XML 69 R58.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Assets $ 9,526.9   $ 9,364.1
Interest expense (12.0) $ (12.3)  
Foreign Currency Transaction Gain (Loss), before Tax 2.7 2.0  
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 83.4 491.1  
Marketable Securities, Unrealized Gain (Loss) 31.8 422.2  
Other Nonoperating Income (Expense) 37.2 34.6  
Other Nonoperating (Income) 0.5 0.8  
Net sales 585.4 610.8  
Cost of goods sold 279.4 284.9  
Gross profit 306.0 325.9  
Selling, general and administrative expense (208.8) (214.9)  
Research and Development Expense (73.5) (66.4)  
Life Science      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net sales 228.6 241.7  
Cost of goods sold 100.2 110.0  
Depreciation, Depletion and Amortization 17.0 16.3  
Gross profit 128.4 131.7  
Other Operating Segment      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net sales 0.0 0.5  
Cost of goods sold 0.0 0.6  
Depreciation, Depletion and Amortization 0.0 0.0  
Gross profit 0.0 (0.1)  
Clinical Diagnostics      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Net sales 356.8 368.6  
Cost of goods sold 179.2 174.3  
Depreciation, Depletion and Amortization 21.1 20.8  
Gross profit 177.6 194.3  
Operating Segments      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Gross profit 306.0 325.9  
Selling, general and administrative expense (208.8) (214.9)  
Research and Development Expense (73.5) (66.4)  
Operating Segments | Life Science      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Assets 308.1 291.7  
Operating Segments | Other Operating Segment      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Assets 0.0 0.0  
Operating Segments | Clinical Diagnostics      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Assets 482.0 491.7  
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Foreign Currency Transaction Gain (Loss), before Tax 2.7 2.0  
Marketable Securities, Unrealized Gain (Loss) 31.8 422.2  
Other Nonoperating Income (Expense) 37.2 34.6  
Interest Expense | Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Interest expense $ (12.0) $ (12.3)